US 11827877
Compositions and methods for genomic editing by insertion of donor polynucleotides
granted A61KA61K48/00A61K48/0025
Quick answer
US patent 11827877 (Compositions and methods for genomic editing by insertion of donor polynucleotides) held by CRISPR THERAPEUTICS AG expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CRISPR THERAPEUTICS AG
- Grant date
- Tue Nov 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K48/00, A61K48/0025